Prolong Pharmaceuticals: Clinical Trials

1 trial sponsored by Prolong Pharmaceuticals, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1
Phase 31Completed 1

Follow Prolong Pharmaceuticals: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of SANGUINATEā„¢ for Reduction of Delayed Graft Function in Patients Receiving a Kidney Transplant
SANGUINATE, Normal Saline - Delayed Function of Renal Transplant
Phase 2 / Phase 3CompletedProlong Pharmaceuticals602015-08-012016-10-27

Interventions

PEGylated carboxyhemoglobin bovine (1)  ·  Saline Solution (1)

Countries

United States (1)

Top investigators

Hemant Misra, PhD (1)